Federal contractor · SAN DIEGO, CA
TRILINK BIOTECHNOLOGIES, LLC
TRILINK BIOTECHNOLOGIES, LLC received -$4.89 in federal contract obligations in FY2026, on 1 awards (−100% vs FY2025). Since FY2017: $303.4K. Its largest customer was National Institutes of Health (-$4.89).
- Obligations · FY2026
- -$4.89
- New awards
- 1
- Sole-source
- —
- Single offer
- —
- UEI
- JTZNJ1K5HUA4
Spending by fiscal year
Obligations per federal fiscal year (October–September).
- 10.1KFY2017
- 10.5KFY2020
- 47.1KFY2021
- 29.6KFY2022
- 35KFY2023
- 21.1KFY2024
- 150KFY2025
- -4.9FY2026
Top buying agencies
Obligations in FY2026.
- National Institutes of Health-$4.890.0%1 awards
What was bought · Where the work was performed
Obligations in FY2026.
What was bought
Where the work was performed
Integrity signals
Shares of the year's obligations, next to the country's.
Largest awards
- National Institutes of Health· San Diego County, CA· Health & medical· Aug 19, 2022 – May 12, 2026· 75N95022P00519
Federal grants & assistance received
Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.
TRILINK BIOTECHNOLOGIES, LLC received $0 in federal assistance in FY2026, on 1 actions (0 new awards).
- Assistance · FY2026
- $0
- New awards
- 0
- Actions
- 1
- Since FY2022
- $40.8M
Assistance by fiscal year
- 38.8MFY2022
- 2MFY2023
- 0FY2024
- 0FY2025
- 0FY2026
Largest awards
- 93.360 · Biomedical Advanced Research and Development Authority (Barda), Biodefense Medical Countermeasure Development· Office of Assistant Secretary for Preparedness and Response· Cooperative agreement· Dec 29, 2022 – Jul 17, 2026· IDSEP230060
Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2022–FY2026.
Competitors
Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.
Compared on 3 markets (agency × industry), FY2024–FY2026.
- BIOIVT, LLC$768.1K−81% in FY2026WOODBURY, NY · 2 entities · 32% of this company's obligations are in markets they both serveEnvironmental Protection Agency · Pharmaceutical and medicine manufacturingNational Institutes of Health · Pharmaceutical and medicine manufacturingNational Institutes of Health · Architectural, engineering, and related services
- EUROFINS FOOD CHEMISTRY TESTING MADISON, INC$2.1M−40% in FY2026MADISON, WI · 16 entities · 44% of this company's obligations are in markets they both serveEnvironmental Protection Agency · Pharmaceutical and medicine manufacturingNational Institutes of Health · Architectural, engineering, and related services
- QIAGEN, LLC$17.9M−19% in FY2026GERMANTOWN, MD · 82% of this company's obligations are in markets they both serveEnvironmental Protection Agency · Pharmaceutical and medicine manufacturingNational Institutes of Health · Pharmaceutical and medicine manufacturingNational Institutes of Health · Architectural, engineering, and related services
Showing the top 3 of 5 competitors. Open the profile for the full list.
Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026 · FY2024–FY2026.
Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 9, 2026, loaded Oct 9, 2026.